يعرض 61 - 80 نتائج من 68,010 نتيجة بحث عن '(( 5 ((nn decrease) OR (a decrease)) ) OR ((( 50 we decrease ) OR ( 100 due decrease ))))', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 61

    Image 1_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif حسب Ying Ye (72583)

    منشور في 2025
    "…</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
  2. 62
  3. 63

    Image5_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF حسب Gabriella Gálffy (177759)

    منشور في 2024
    "…The COVID-19 pandemic resulted in a statistically significant decrease in lung cancer incidence, especially in the 50–59 age group (both sexes).…"
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69

    Advancing the science of NOWS research. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
  10. 70

    Protocol measures. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
  11. 71

    Cry variables. حسب Sarah E. Maylott (14560785)

    منشور في 2024
    "…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76

    Flow chart of the study procedures. حسب Kazuhiko Ikeuchi (9234268)

    منشور في 2023
    "…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…"
  17. 77
  18. 78
  19. 79
  20. 80

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... حسب Shuai Wang (109515)

    منشور في 2021
    "…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …"